| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 3.180 | 6.994 | 13.408 | 12.655 | 29.050 | 51.066 | 30.281 | 49.668 |
| Total Income - EUR | - | - | 4.732 | 7.661 | 13.556 | 12.655 | 29.050 | 51.066 | 30.613 | 51.097 |
| Total Expenses - EUR | - | - | 1.259 | 3.402 | 3.793 | 2.678 | 3.443 | 5.097 | 6.092 | 9.391 |
| Gross Profit/Loss - EUR | - | - | 3.472 | 4.259 | 9.762 | 9.976 | 25.607 | 45.969 | 24.521 | 41.706 |
| Net Profit/Loss - EUR | - | - | 3.330 | 4.029 | 9.356 | 9.623 | 24.840 | 44.468 | 20.312 | 34.832 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Eligyn Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 58 | 57 | 56 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 3.390 | 4.056 | 9.472 | 9.894 | 33.643 | 48.595 | 37.235 | 77.297 |
| Inventories | - | - | 0 | 343 | 336 | 330 | 322 | 323 | 322 | 0 |
| Receivables | - | - | 7 | 322 | 259 | 641 | 279 | 21.345 | 612 | 35.673 |
| Cash | - | - | 3.383 | 3.391 | 8.877 | 8.924 | 33.041 | 26.926 | 36.301 | 41.625 |
| Shareholders Funds | - | - | 3.374 | 4.096 | 9.406 | 9.771 | 30.139 | 48.232 | 35.252 | 34.880 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 74 | 17 | 122 | 123 | 3.504 | 363 | 1.983 | 42.432 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Eligyn Med Srl